▶ MOTS-C · SUBTOPIC · MECHANISM
MOTS-c Mechanism
For Laboratory Research Use Only. The mechanistic information below is descriptive of published research. No human dose is recommended. No clinical claim is made.
MECHANISM OF ACTION
16-amino-acid peptide encoded by a short open reading frame within the mitochondrial 12S rRNA. Activates the AMPK pathway in cell-culture and animal-model studies.
PHARMACOKINETIC HALF-LIFE
Reported half-life for MOTS-c: ~30 min plasma (rodent), longer tissue residence. Half-life determines the kinetic window across which receptor occupancy is maintained and frames the dosing rhythm used in published literature.
PRIMARY SEQUENCE
MOTS-c is a defined sequence: MRWQEMGYIFYPRKLR. Synthesis proceeds via solid-phase peptide synthesis with HPLC-verified identity confirmation.
MECHANISM CATEGORIES
MOTS-c is tagged in 3 mechanism categories on GIGARESEARCH. Each category aggregates the broader pharmacology of related compounds.
Compounds acting on metabolic regulation include incretin agonists (GLP-1, GIP, glucagon), AMPK activators (MOTS-c), and GHRH analogs that drive lipolysis (tesamorelin). The shared therapeutic target is metabolic dysfunction underlying obesity, type 2 diabetes, NAFLD, and the broader cardiometabolic syndrome.
Mitochondrial function encompasses oxidative phosphorylation, biogenesis (driven by PGC-1α), and quality-control processes (mitophagy). The mitochondrial-derived peptide MOTS-c regulates AMPK signaling and metabolic homeostasis. NAD+ supports the electron-transport chain and mitochondrial sirtuins (SIRT3, SIRT4, SIRT5).
Exercise mimetics are compounds that activate signaling pathways normally triggered by physical exercise · AMPK, PGC-1α-driven mitochondrial biogenesis, GLUT4 translocation, and FNDC5/irisin secretion. MOTS-c is the canonical example, released from mitochondria during exercise and reproducing many of the metabolic-conditioning effects in sedentary aged rodents.
MECHANISTIC OUTCOMES IN LITERATURE
The following outcomes are the mechanistic endpoints reported in the peer-reviewed literature, with GIGARESEARCH evidence grades. Grades reflect study quality and replication, not clinical recommendation.
Lee, Cohen et al. 2015 (Cell Metab, PMID 25738459) · the discovery paper showed MOTS-c reversed insulin resistance in mice.
Reynolds JC et al. 2021 (Nat Commun, PMID 33473109) · MOTS-c improved treadmill performance and grip strength in aged mice.
Mechanism well-characterized. MOTS-c inhibits the folate cycle and de novo purine biosynthesis, activating AMPK.
Early-stage. Several small studies on insulin-resistance populations listed on ClinicalTrials.gov; no Phase 3 completions.
MECHANISM Q+A
▶ MOTS-c mechanism of action?
MOTS-c translocates to the cell nucleus under metabolic stress (glucose deprivation, oxidative stress, exercise), where it modulates nuclear gene expression in response to mitochondrial state. It activates AMPK, enhances glucose uptake in skeletal muscle independently of insulin, and improves insulin sensitivity in diet-induced obese rodent models.
▶ MOTS-c vs metformin · which activates AMPK better?
Both activate AMPK, by different upstream mechanisms. Metformin inhibits complex I of the electron-transport chain, raising AMP and triggering AMPK via LKB1. MOTS-c inhibits the folate cycle and de novo purine biosynthesis. No head-to-head clinical comparison exists.
CITED LITERATURE
- Lee C, Zeng J, Drew BG, et al.. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab 2015. PMID 25738459. link
- Reynolds JC, Lai RW, Woodhead JST, et al.. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun 2021. PMID 33473109. link
- Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression. Cell Metab 2018. PMID 29983246. link
RELATED PAGES
▶ LAST UPDATED · 2026-05-19